Cargando…

The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo

The genetic and metabolic heterogeneity of RAS-driven cancers has confounded therapeutic strategies in the clinic. To address this, rapid and genetically tractable animal models are needed that recapitulate the heterogeneity of RAS-driven cancers in vivo. Here, we generate a Drosophila melanogaster...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rackley, Briana, Seong, Chang-Soo, Kiely, Evan, Parker, Rebecca E., Rupji, Manali, Dwivedi, Bhakti, Heddleston, John M., Giang, William, Anthony, Neil, Chew, Teng-Leong, Gilbert-Ross, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846793/ https://www.ncbi.nlm.nih.gov/pubmed/33514834 http://dx.doi.org/10.1038/s42003-021-01663-8

Ejemplares similares

Oncogenic Ras cooperates with knockdown of the tumor suppressor Lkb1 by RNAi to override organ size limits in Drosophila wing tissue
por: Rackley, Briana Brown, et al.
Publicado: (2020)

NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis
por: Rupji, Manali, et al.
Publicado: (2019)

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis
por: Seong, Chang-Soo, et al.
Publicado: (2023)

Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer
por: Koo, Junghui, et al.
Publicado: (2023)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma()
por: Siegel, Benjamin I, et al.
Publicado: (2019)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant
por: Tago, Kenji, et al.
Publicado: (2017)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
por: Shin, Seung-Min, et al.
Publicado: (2020)

Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants
por: Khan, Imran, et al.
Publicado: (2022)

Visualizing the Invisible: Advanced Optical Microscopy as a Tool to Measure Biomechanical Forces
por: Hobson, Chad M., et al.
Publicado: (2021)

The Importance of Mg(2+)‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
por: Pálfy, Gyula, et al.
Publicado: (2022)

Developmentally programmed germ cell remodeling by endodermal cell cannibalism
por: Abdu, Yusuff, et al.
Publicado: (2016)

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
por: Zubiete-Franco, Imanol, et al.
Publicado: (2018)

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
por: Wu, Y, et al.
Publicado: (2000)

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
por: Lock, Rebecca, et al.
Publicado: (2011)

Requirement for c-ras proteins during viral oncogene transformation
por: Smith, Mark R., et al.
Publicado: (1986)

Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line
por: Tokunaga, T, et al.
Publicado: (2000)

CASAS: Cancer Survival Analysis Suite, a web based application
por: Rupji, Manali, et al.
Publicado: (2017)

GAC: Gene Associations with Clinical, a web based application
por: Zhang, Xinyan, et al.
Publicado: (2018)

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells
por: Trapp, Elisabeth Katharina, et al.
Publicado: (2017)

Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
por: Shin, Seung-Min, et al.
Publicado: (2017)

Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation
por: Tago, Kenji, et al.
Publicado: (2019)

Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation
por: Kim, Min-Jung, et al.
Publicado: (2011)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma
por: Wang, Guanghui, et al.
Publicado: (2018)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway
por: Wu, C-H, et al.
Publicado: (2002)

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide
Publicado: (1994)

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene
Publicado: (1995)

Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras
por: Lee, Tae Hoon, et al.
Publicado: (2016)

The Expression of Tumor Rejection Antigen on Rat Fetus Fibroblasts Transformed by the ras Oncogene
por: Okubo, Mamoru, et al.
Publicado: (1988)

Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
por: Huffman, Kenneth E., et al.
Publicado: (2023)

A subset of VEGFR‐TKIs activates AMPK in LKB1‐mutant lung cancer
por: Yang, Lujie, et al.
Publicado: (2022)

The role of RAS oncogenes in controlling epithelial mechanics
por: Nyga, Agata, et al.
Publicado: (2023)

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
por: Zheng, Kang, et al.
Publicado: (2023)

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene
por: Vitiello, Michela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tn07ggcl6khnusqlo8h92pus3t